Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Hepatitis C

Free Subscription Articles published in Eur J Gastroenterol Hepatol Retrieve available abstracts of 36 articles: HTML format

Single Articles

May 2008
1. ABE S , Narita R, Matsuhashi T, Oto T, et al
   Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C.
   Eur J Gastroenterol Hepatol. 2008;20:373-8.
   PubMed     Related articles    Abstract available
   
   
   
2. DEFOSSEZ G , Verneau A, Ingrand I, Silvain C, et al
   Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
   Eur J Gastroenterol Hepatol. 2008;20:367-372.
   PubMed     Related articles    Abstract available
   
   
   April 2008
3. LUBRANO J , Rouquette A, Huet E, Francois A, et al
   Ciliated hepatic foregut cyst discovered after kidney transplantation in a hepatitis C virus-infected patient: a report of one case and review of the literature.
   Eur J Gastroenterol Hepatol. 2008;20:359-61.
   PubMed     Related articles    Abstract available
   
   
   February 2008
4. SJOBERG K , Widell A, Verbaan H
   Prevalence of hepatitis C in Swedish diabetics is low and comparable to that in health care workers.
   Eur J Gastroenterol Hepatol. 2008;20:135-8.
   PubMed     Related articles    Abstract available
   
   
   January 2008
5. QUER J , Esteban JI, Sanchez JM, Otero T, et al
   Nosocomial transmission of hepatitis C virus during contrast-enhanced computed tomography scanning.
   Eur J Gastroenterol Hepatol. 2008;20:73-78.
   PubMed     Related articles    Abstract available
   
   
   
6. FISCHER B , Powis J, Cruz MF, Rudzinski K, et al
   Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia.
   Eur J Gastroenterol Hepatol. 2008;20:29-32.
   PubMed     Related articles    Abstract available
   
   
   November 2007
7. GIANNITRAPANI L , Soresi M, Ingrao S, La Spada E, et al
   Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C.
   Eur J Gastroenterol Hepatol. 2007;19:927-933.
   PubMed     Related articles    Abstract available
   
   
   October 2007
8. POTTHOFF A , Deterding K, Trautwein C, Rifai K, et al
   Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
   Eur J Gastroenterol Hepatol. 2007;19:906-9.
   PubMed     Related articles    Abstract available
   
   
   September 2007
9. KARTAL ED , Alpat SN, Ozgunes I, Usluer G, et al
   Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
   Eur J Gastroenterol Hepatol. 2007;19:817-20.
   PubMed     Related articles    Abstract available
   
   
   
10. YURCI A , Guven K, Torun E, Gursoy S, et al
    Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2007;19:811-5.
    PubMed     Related articles    Abstract available
    
    
    
11. SYLVESTRE DL , Clements BJ
    Adherence to hepatitis C treatment in recovering heroin users maintained on methadone.
    Eur J Gastroenterol Hepatol. 2007;19:741-7.
    PubMed     Related articles    Abstract available
    
    
    
12. NAKAMURA J , Kobayashi K, Toyabe S, Aoyagi Y, et al
    The cost-effectiveness of the new protocol reflecting rapid virologic response to peginterferon alpha-2b and ribavirin for chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2007;19:733-9.
    PubMed     Related articles    Abstract available
    
    
    August 2007
13. BELFIORI B , Chiodera A, Ciliegi P, Tosti A, et al
    Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study.
    Eur J Gastroenterol Hepatol. 2007;19:731-732.
    PubMed     Related articles   
    
    
    
14. ANTY R , Gelsi E, Giudicelli J, Marine-Barjoan E, et al
    Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
    Eur J Gastroenterol Hepatol. 2007;19:671-677.
    PubMed     Related articles    Abstract available
    
    
    
15. MICHELE G , Carlo L, Mario MC, Giovanni L, et al
    Hepatitis C virus chronic infection and oral lichen planus: an Italian case-control study.
    Eur J Gastroenterol Hepatol. 2007;19:647-652.
    PubMed     Related articles    Abstract available
    
    
    
16. KRONENBERGER B , Berg T, Herrmann E, Hinrichsen H, et al
    Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.
    Eur J Gastroenterol Hepatol. 2007;19:639-646.
    PubMed     Related articles    Abstract available
    
    
    
17. FUNG KT , Fung J, Lai CL, Yuen MF, et al
    Etiologies of chronic liver diseases in Hong Kong.
    Eur J Gastroenterol Hepatol. 2007;19:659-64.
    PubMed     Related articles    Abstract available
    
    
    June 2007
18. SMYTH CM , McKiernan SM, Hagan R, Pilkington R, et al
    Chronic hepatitis C infection and sicca syndrome: a clear association with HLA DQB1*02.
    Eur J Gastroenterol Hepatol. 2007;19:493-498.
    PubMed     Related articles    Abstract available
    
    
    February 2007
19. ROCHA CM , Perez RM, Narciso JL, Ferreira AP, et al
    Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Eur J Gastroenterol Hepatol. 2007;19:119-23.
    PubMed     Related articles    Abstract available
    
    
    January 2007
20. TREBST C , Wedemeyer H, Manns MP, Tillmann H, et al
    Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin.
    Eur J Gastroenterol Hepatol. 2007;19:91-2.
    PubMed     Related articles    Abstract available
    
    
    December 2006
21. LIN L , Verslype C, van Pelt JF, van Ranst M, et al
    Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses.
    Eur J Gastroenterol Hepatol. 2006;18:1311-9.
    PubMed     Related articles    Abstract available
    
    
    
22. PISCAGLIA F , Cucchetti A, Benlloch S, Vivarelli M, et al
    Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors.
    Eur J Gastroenterol Hepatol. 2006;18:1255-61.
    PubMed     Related articles    Abstract available
    
    
    November 2006
23. ELEFSINIOTIS IS , Pantazis KD, Ketikoglou ID, Koutsounas SI, et al
    Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
    Eur J Gastroenterol Hepatol. 2006;18:1227-31.
    PubMed     Related articles    Abstract available
    
    
    October 2006
24. CHONG VH , Jamaludin AZ, Jacob AP, Jalihal A, et al
    Treating intravenous drug users with hepatitis C infection: an opportunity in some settings.
    Eur J Gastroenterol Hepatol. 2006;18:1121.
    PubMed     Related articles   
    
    
    
25. BURRA P , Buda A, Livi U, Rigotti P, et al
    Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Eur J Gastroenterol Hepatol. 2006;18:1065-70.
    PubMed     Related articles    Abstract available
    
    
    
26. SYLVESTRE DL , Clements BJ, Malibu Y
    Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.
    Eur J Gastroenterol Hepatol. 2006;18:1057-63.
    PubMed     Related articles    Abstract available
    
    
    
27. FISCHER B , Reimer J, Firestone M, Kalousek K, et al
    Treatment for hepatitis C virus and cannabis use in illicit drug user patients: implications and questions.
    Eur J Gastroenterol Hepatol. 2006;18:1039-42.
    PubMed     Related articles    Abstract available
    
    
    September 2006
28. RAUTOU PE , Asselah T, Saadoun D, Martinot M, et al
    Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfection.
    Eur J Gastroenterol Hepatol. 2006;18:1019-1022.
    PubMed     Related articles    Abstract available
    
    
    
29. WIETZKE-BRAUN P , Maouzi AB, Manhardt LB, Bickeboller H, et al
    Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2006;18:991-7.
    PubMed     Related articles    Abstract available
    
    
    
30. GROENBAEK K , Friis H, Hansen M, Ring-Larsen H, et al
    The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients.
    Eur J Gastroenterol Hepatol. 2006;18:985-989.
    PubMed     Related articles    Abstract available
    
    
    July 2006
31. DELWAIDE J , Reenaers C, Gerard C, Vaira D, et al
    HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin.
    Eur J Gastroenterol Hepatol. 2006;18:707-712.
    PubMed     Related articles    Abstract available
    
    
    June 2006
32. RIDRUEJO E , Christensen AF, Mando OG
    Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin.
    Eur J Gastroenterol Hepatol. 2006;18:693-694.
    PubMed     Related articles    Abstract available
    
    
    
33. COZZOLONGO R , Betterle C, Fabris P, Paola Albergoni M, et al
    Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2006;18:689-692.
    PubMed     Related articles    Abstract available
    
    
    May 2006
34. SCOTT BB , Egner W
    Does alpha1-antitrypsin phenotype PiMZ increase the risk of fibrosis in liver disease due to hepatitis C virus infection?
    Eur J Gastroenterol Hepatol. 2006;18:521-3.
    PubMed     Related articles    Abstract available
    
    
    
35. BISELLI M , Andreone P, Gramenzi A, Cursaro C, et al
    Acquired intestinal lymphangiectasia successfully treated with a low-fat and medium-chain triacylglycerol-enriched diet in a patient with liver transplantation.
    Eur J Gastroenterol Hepatol. 2006;18:561-4.
    PubMed     Related articles    Abstract available
    
    
    April 2006
36. CHRYSANTHOS NV , Papatheodoridis GV, Savvas S, Kafiri G, et al
    Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis.
    Eur J Gastroenterol Hepatol. 2006;18:389-396.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: